Ivette Suarrez Arroyo PhD Cell and Molecular biology (Universidad Central Del Caribe); B.S. Industrial Microbiology (University of Puerto Rico Mayaguez Campus)

Dr. Ivette Suarrez Arroyo is an Assistant Professor at Universidad Central Del Caribe in Bayamon, Puerto Rico. She earned her PhD and completed her education at Universidad Central Del Caribe and the University of Puerto Rico Mayaguez Campus. Dr. Suarrez Arroyo's research focuses on cell biology, molecular biology, and cancer biology, with particular emphasis on breast cancer and inflammatory breast cancer. Her most-cited work, "Theoretical Prediction of Gastrointestinal Absorption of Phytochemicals" (2022), has been cited 30 times and reflects her contributions to understanding phytochemical bioavailability in relation to cancer research.

• ​Medicines Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer.
• The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease.
• Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression.
• Abstract B20: Combination of Ganoderma lucidum extract and erlotinib decreases IBC progression.
• PO133 DIFFERENTIAL EXPRESSION OF PLASMA MEMBRANE PROTEINS IN INFLAMMATORY BREAST CANCER VIA STABLE ISOTOPE LABELED AMINO ACIDS IN CULTURE (SILAC).
• Abstract 5556: Enhancing response of Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells.
• Abstract 3219: Synergistic effect between Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells.
• Abstract 3212: Ganoderma lucidum (Reishi) chemosensitizes EGFR-overexpressing inflammatory breast cancer cells to erlotinib.
• Abstract 2247: Ganoderma lucidum (Reishi) downregulates key proteins overexpressed in IBC and chemosensitizes EGFR-overexpressing cells to erlotinib.
• Abstract 1672: Ganoderma lucidum (Reishi) induces autophagy in inflammatory breast cancer cells to promote cell death.
• Anti-Tumor Effects of Ganoderma lucidum (Reishi) in Inflammatory Breast Cancer in In Vivo and In Vitro Models.
• Abstract 1987: Ganoderma lucidum (Reishi) suppresses key protein synthesis initiation molecules in inflammatory breast cancer.
• Abstract 1992: Ganoderma lucidum (Reishi) induces autophagy in inflammatory breast cancer by regulation of the mTOR signaling pathway.